These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6181037)

  • 1. Antigen-specific human T-lymphocyte clones. Genetic restriction of influenza virus-specific responses to HLA-D region genes.
    Eckels DD; Lamb JR; Lake P; Woody JN; Johnson AH; Hartzman RJ
    Hum Immunol; 1982 Jul; 4(4):313-24. PubMed ID: 6181037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homozygous typing cell-defined HLA-Dw specificities correlate better than serologically defined HLA-DR specificities with restriction elements for influenza virus-specific proliferative human T lymphocyte clones.
    Fleischer B; Pawelec G; Wernet P
    Hum Immunol; 1985 Sep; 14(1):37-47. PubMed ID: 2411701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of human T-lymphocyte clones (TLCs) specific for HLA-region gene products.
    Eckels DD; Hartzman RJ
    Immunogenetics; 1982; 16(2):117-33. PubMed ID: 6183195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen-specific human T lymphocyte clones: induction, antigen specificity, and MHC restriction of influenza virus-immune clones.
    Lamb JR; Eckels DD; Lake P; Johnson AH; Hartzman RJ; Woody JN
    J Immunol; 1982 Jan; 128(1):233-8. PubMed ID: 6172480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-specific T cell clones restricted by DR, DRw53 (MT), or DP (SB) Class II HLA molecules. Inhibition studies with monoclonal HLA-specific antibodies.
    Qvigstad E; Gaudernack G; Thorsby E
    Hum Immunol; 1984 Dec; 11(4):207-17. PubMed ID: 6210280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human influenza virus-specific T helper cell clones can be restricted by MHC products different from serologically defined HLA-DR antigens.
    Fleischer B
    Tissue Antigens; 1983 Mar; 21(3):238-45. PubMed ID: 6190261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presentation of influenza hemagglutinin peptide in the presence of limited allostimulation by HLA-DR1 transfected human fibroblasts.
    Eckels DD; Sell TW; Long EO; Sekaly RP
    Hum Immunol; 1988 Mar; 21(3):173-81. PubMed ID: 2453491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza A hemagglutinin-specific T cell clones strictly restricted by HLA-DR1 or HLA-DR7 molecules.
    Sterkers G; Henin Y; Lepage V; Fradelizzi D; Hannoun C; Levy JP
    Eur J Immunol; 1984 Feb; 14(2):125-32. PubMed ID: 6199211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human allospecific TLCs generated against HLA antigens associated with DR1 through DRw8. II. Population analyses and blocking studies with monoclonal antibodies.
    Rosen-Bronson S; Johnson AH; Hartzman RJ; Eckels DD
    Immunogenetics; 1986; 24(5):286-97. PubMed ID: 3491043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.
    Yasukawa M; Zarling JM
    J Immunol; 1984 Jul; 133(1):422-7. PubMed ID: 6609990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An influenza A virus-specific and HLA-DRw8-restricted T cell clone cross-reacting with a transcomplementation product of the HLA-DR2 and DR4 haplotypes.
    Gomard E; Hénin Y; Sterkers G; Masset M; Fauchet R; Lévy JP
    J Immunol; 1986 Jun; 136(11):3961-7. PubMed ID: 2422266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major histocompatibility complex (MHC) restricted antigen recognition: high frequency of human T-cell clones recognizing novel MHC class II determinants.
    Nisbet-Brown E; Lee JW; Letarte M; Falk JA; Gelfand EW
    Hum Immunol; 1987 May; 19(1):41-52. PubMed ID: 2438261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic human HLA class II restricted purified protein derivative-reactive T-lymphocyte clones. IV. Analysis of HLA restriction pattern and mycobacterial antigen specificity.
    Hansen PW; Petersen CM; Povlsen JV; Kristensen T
    Scand J Immunol; 1987 Mar; 25(3):295-303. PubMed ID: 3494302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major histocompatibility complex restriction of tetanus toxoid-specific human T lymphocyte clones.
    Schmitt C; Cogné M; Agrapart M; Ballet JJ
    Eur J Immunol; 1984 Dec; 14(12):1131-6. PubMed ID: 6083872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DR-, MB- and novel DC-related determinants restrict purified protein derivative of tuberculin (PPD)-stimulated human T cell proliferation.
    Pawelec G; Schneider EM; Müller C; Wernet P
    Eur J Immunol; 1985 Jan; 15(1):12-7. PubMed ID: 2578396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional studies of HLA-DR restricted antigen recognition by human helper T lymphocyte clones by using transfected murine cell lines.
    Lechler RI; Bal V; Rothbard JB; Germain RN; Sekaly R; Long EO; Lamb J
    J Immunol; 1988 Nov; 141(9):3003-9. PubMed ID: 2459238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SB-restricted presentation of influenza and herpes simplex virus antigens to human T-lymphocyte clones.
    Eckels DD; Lake P; Lamb JR; Johnson AH; Shaw S; Woody JN; Hartzman RJ
    Nature; 1983 Feb; 301(5902):716-8. PubMed ID: 6186920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human helper T-cell clones that recognize different influenza hemagglutinin determinants are restricted by different HLA-D region epitopes.
    Eckels DD; Sell TW; Bronson SR; Johnson AH; Hartzman RJ; Lamb JR
    Immunogenetics; 1984; 19(5):409-23. PubMed ID: 6202629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential inhibition of human antigen-specific T cell clone proliferative responses by distinct monoclonal anti-HLA-DR antibodies.
    Triebel F; Missenard-Leblond V; Couty MC; Charron DJ; Debre P
    J Immunol; 1984 Apr; 132(4):1773-8. PubMed ID: 6199412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
    Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
    J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.